HLA-DRB1 and myeloid sarcoma: It is notable that 2 OND patients who had high levels of anti-PLP antibodies but who did not carry typical PLP response-permissive HLA types both carried DRB1*10 alleles (which occur very infrequently in MS patients – only one MS patient in this study carried DRB1*10).